As shown in Figure S8A, A375-R1 and A375-R2 melanoma cells exhibited significantly increased expression of PRKCA, PRKCE and PRKCI compared to their BRAFi-sensitive counterpart. This evidence concerns the gene PRKCI and melanoma.